These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31319697)

  • 21. An investment in the Three Rs can be very profitable.
    Curren R
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():35-8. PubMed ID: 20105009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in replacing, reducing, and refining animal use in toxicologic research and testing.
    Gad SC
    Fundam Appl Toxicol; 1990 Jul; 15(1):8-16. PubMed ID: 2197147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Legal aspects of alternative methods to animal testing].
    Quesne A
    Biol Aujourdhui; 2023; 217(3-4):207-211. PubMed ID: 38018948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternatives to animal experimentation in basic research.
    Gruber FP; Hartung T
    ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing a Three Rs programme at the Canadian Council on Animal Care.
    Griffin G
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():63-7. PubMed ID: 20105015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of progress with the replacement of animal models in medical research.
    Goodman C
    Altern Lab Anim; 2006 Feb; 34(1):127. PubMed ID: 16541526
    [No Abstract]   [Full Text] [Related]  

  • 28. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal experimentation.
    Kolar R
    Sci Eng Ethics; 2006 Jan; 12(1):111-22. PubMed ID: 16501652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Estimate of the Number of Animals Used for Scientific Purposes Worldwide in 2015.
    Taylor K; Alvarez LR
    Altern Lab Anim; 2019; 47(5-6):196-213. PubMed ID: 32090616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Third FRAME Toxicity Committee: working toward greater implementation of alternatives in toxicity testing.
    Combes RD; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizou G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():635-42. PubMed ID: 23581152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in applying the three Rs of Russell & Burch to the testing of biological products.
    Balls M; Halder M
    Dev Biol (Basel); 2002; 111():3-13. PubMed ID: 12678219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. It's Time to Reconsider
    Balls M
    Altern Lab Anim; 2020 Jan; 48(1):40-46. PubMed ID: 32316753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FRAME, animal experimentation and the Three Rs: past, present and future.
    Balls M
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():1-6. PubMed ID: 20105003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Searching and review on the Three Rs information in Korea: time for quality assessment and continued education.
    Choe BI; Lee GH
    BMB Rep; 2013 Jul; 46(7):335-7. PubMed ID: 23884098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ethical issue in animal experimentation].
    Parodi AL
    Bull Acad Natl Med; 2009 Nov; 193(8):1737-45; discussion 1746. PubMed ID: 20669538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressing toward the reduction, refinement and replacement of laboratory animal procedures: thoughts on some encounters with Dr Iain Purchase.
    Balls M
    Toxicol In Vitro; 2004 Apr; 18(2):165-70. PubMed ID: 14757106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reporting the implementation of the Three Rs in European primate and mouse research papers: are we making progress?
    Taylor K
    Altern Lab Anim; 2010 Dec; 38(6):495-517. PubMed ID: 21275472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Animal experimentation in Japan: regulatory processes and application for microbiological studies.
    Takahashi-Omoe H; Omoe K
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):225-46. PubMed ID: 17416418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.